Company | Datadog, Inc. |
Ticker | DDOG (NASDAQ) |
Reporting Period | Q2 2026 (quarter ended June 30, 2026) |
Earnings Date | August 6, 2026 (pre-market); conference call 8:00 a.m. ET |
Prepared | August 5, 2026 |
Key Takeaway: The setup favors a beat — consensus sits at the low end of guidance, estimates have risen sharply since the Q1 print, and every peer read-through points to accelerating AI-driven cloud consumption; the single biggest swing factor is whether the largest AI customer (where management applies heightened conservatism) surprises to the upside.
Heading into Q2 2026 results, Datadog's bar looks beatable. Consensus revenue of ~$1.080B sits at the midpoint of the $1.07–$1.08B guidance range issued on May 7, and the company has beaten the top of its own guidance range in each of the last several quarters. Management's tone since the Q1 print has been unambiguously constructive: CFO David Obstler described a "good buying environment" at the BofA Tech Conference (June 3), CEO Olivier Pomel reiterated a 5–10× long-term opportunity at the Bernstein conference (May 28), and April trends were called out explicitly as a continuation of Q1's record ARR momentum. Estimate revisions have moved sharply higher since the Q1 beat — the non-GAAP EPS consensus for Q2 jumped from $0.51 to $0.59 in the weeks following the May 7 print — suggesting the Street has already re-rated the story, though the stock's ~50% rally since earnings means a meaningful beat is likely needed to drive further upside. The wildcard is the largest AI customer: management applies a "higher degree of conservatism" to this account in guidance, meaning any upside surprise there could drive a material revenue beat, while a deceleration would be the primary downside risk.
Key Takeaway: Consensus sits at the midpoint of guidance across all key metrics, representing a low-to-moderate bar given DDOG's consistent history of beating the top of its own range. Revenue growth and $100K+ customer additions are the two biggest swing factors for the stock reaction.
KPI | Q1 2026 Actual | Q2 2025 Actual (Prior Year) | Q2 2026 Consensus Estimate | YoY Change | Q2 2026 Guidance | Consensus vs. Guidance Midpoint |
Total Revenue ($M) | $1,006.4 | $826.8 | $1,079.7 | +30.6% | $1,070–$1,080 | +0.0% (at midpoint) |
Non-GAAP EPS (Diluted) | $0.60 | $0.46 | $0.59 | +28.3% | $0.57–$0.59 | +0.0% (at top of range) |
Dollar-Based Net Retention Rate (NRR) | ~122% (low 120s) | 120% | ~122% | +~200 bps | No guidance provided | N/A |
Customers with $100K+ ARR (#) | 4,550 | 3,850 | 4,584 | +19.1% | No guidance provided | N/A |
Free Cash Flow ($M) | $289.1 | $165.4 | $221.6 | +34.0% | No guidance provided | N/A |
Source: Visible Alpha Consensus and Actuals Data. Revenue, EPS, NRR, $100K+ customers, and FCF actuals and consensus estimates sourced from Visible Alpha. Q2 2026 guidance from DDOG Q1 2026 Earnings Call (May 7, 2026).
Quarter | KPI | Reported | Consensus | Surprise % | Result |
Q1 2026 | Revenue ($M) | $1,006.4 | $959.9 | +4.8% | Beat |
Q1 2026 | Non-GAAP EPS | $0.60 | $0.51 | +17.6% | Beat |
Q4 2025 | Revenue ($M) | $953.2 | $918.2 | +3.8% | Beat |
Q4 2025 | Non-GAAP EPS | $0.59 | $0.56 | +5.4% | Beat |
Q3 2025 | Revenue ($M) | $885.7 | $852.4 | +3.9% | Beat |
Q3 2025 | Non-GAAP EPS | $0.55 | $0.46 | +19.6% | Beat |
Q2 2025 | Revenue ($M) | $826.8 | $791.2 | +4.5% | Beat |
Q2 2025 | Non-GAAP EPS | $0.46 | $0.41 | +12.2% | Beat |
Q1 2025 | Revenue ($M) | $761.6 | $741.0 | +2.8% | Beat |
Q1 2025 | Non-GAAP EPS | $0.46 | $0.43 | +7.0% | Beat |
Q4 2024 | Revenue ($M) | $737.7 | $715.2 | +3.1% | Beat |
Q4 2024 | Non-GAAP EPS | $0.49 | $0.44 | +11.4% | Beat |
Q3 2024 | Revenue ($M) | $690.0 | $664.7 | +3.8% | Beat |
Q3 2024 | Non-GAAP EPS | $0.46 | $0.40 | +15.0% | Beat |
Source: Visible Alpha Consensus and Actuals Data. Pattern: DDOG has beaten consensus revenue in each of the last 8 quarters by an average of ~3.8%, and non-GAAP EPS by an average of ~12%; the Q1 2026 beat was the largest in recent history, raising the bar for Q2.
Key Takeaway: Guidance has not been formally revised since the May 7 earnings call, but management's tone at three investor conferences since then has been consistently and increasingly constructive — no red flags, and several incremental positives on AI demand and sales capacity.
Metric | Initial Guidance (Q1 2026 Earnings Call, May 7, 2026) | Revised Guidance | Current Consensus | Note |
Q2 2026 Revenue | $1,070M – $1,080M (29%–31% YoY) | — | $1,079.7M | No post-earnings revision; consensus at midpoint of range. CFO noted strong April trends and broad-based ARR adds. |
Q2 2026 Non-GAAP Operating Income | $225M – $235M (21%–22% margin) | — | ~$230M (implied) | Includes ~$15M DASH user conference cost. No revision. |
Q2 2026 Non-GAAP EPS | $0.57 – $0.59 (~369M diluted shares) | — | $0.59 | Consensus at top of guidance range. No revision. |
FY 2026 Revenue | $4,300M – $4,340M (25%–27% YoY) | — | $4,356.8M | Consensus slightly above guidance midpoint ($4,320M), reflecting market expectation of continued beats. |
FY 2026 Non-GAAP Operating Income | $940M – $980M (22%–23% margin) | — | ~$960M (implied) | No revision. Guidance philosophy unchanged per CFO. |
FY 2026 Non-GAAP EPS | $2.36 – $2.44 (~372M diluted shares) | — | $2.49 | Consensus above guidance range, reflecting expected beats. No revision. |
Source: DDOG Q1 2026 Earnings Call transcript (May 7, 2026); Visible Alpha Consensus Data. No formal guidance revision has been issued since the Q1 2026 earnings call. Management's tone at the BofA Global Technology Conference (June 3), JP Morgan TMC Conference (May 19), and Bernstein Strategic Decisions Conference (May 28) was consistently positive, with CFO Obstler describing a "good buying environment" and CEO Pomel reiterating the 5–10× long-term opportunity. The DASH user conference (~$15M cost) is already reflected in Q2 operating income guidance.
Key Takeaway: Estimates have moved sharply higher since the Q1 2026 print — Q2 revenue consensus is up ~12% and EPS up ~15% from the post-Q1 baseline — tracking well above the initial guidance midpoint and signaling the Street has already priced in a beat. The gap between consensus and guidance midpoint represents cushion, not risk, given DDOG's consistent beat history.
KPI & Period | Estimate ~5 Days Post Q1 Earnings (as of May 14, 2026) | Current Consensus | Estimate Δ (%) | Initial Guidance (Q1 Earnings Call) | Current Guidance | Guidance Δ | Consensus vs. Guidance Midpoint |
Revenue — Q2 2026 | $1,076.5M | $1,079.7M | +0.3% | $1,070–$1,080M | Unchanged | — | +0.0% (at midpoint) |
Non-GAAP EPS — Q2 2026 | $0.585 | $0.591 | +1.0% | $0.57–$0.59 | Unchanged | — | +0.0% (at top of range) |
Revenue — FY 2026 | $4,343.0M | $4,356.8M | +0.3% | $4,300–$4,340M | Unchanged | — | +0.9% above midpoint |
Non-GAAP EPS — FY 2026 | $2.427 | $2.488 | +2.5% | $2.36–$2.44 | Unchanged | — | +2.0% above midpoint |
Source: Visible Alpha Consensus and Actuals Data (as-of May 14, 2026 and current). Estimates stabilized quickly after the Q1 beat — the large revision happened in the days immediately following the May 7 print. Since mid-May, estimates have drifted only modestly higher, suggesting the Street has largely digested the Q1 upside and is now waiting for Q2 results to re-rate further. FY 2026 consensus sits ~$37M above the guidance midpoint, consistent with the market pricing in one additional beat.
Key Takeaway: DDOG's ~50% rally since the Q1 2026 earnings print has been almost entirely multiple-driven — EV/EBITDA expanded from ~47× to ~81× over the past 3 months — meaning the stock has already priced in a significant re-rating; a beat is likely needed to sustain current levels, and any miss or guidance disappointment could be punished sharply.
DDOG vs. IGV (iShares Expanded Tech-Software ETF) vs. S&P 500 — Indexed to 100 at Q1 2026 Earnings (May 7, 2026). Source: Yahoo Finance / Stock Price Data.
Since the Q1 2026 earnings print on May 7, DDOG has rallied approximately +50% (from $188.73 to ~$283 as of August 5), dramatically outperforming both the iShares Expanded Tech-Software ETF (IGV, +12%) and the S&P 500 (+5%). The stock surged sharply in the days immediately following the Q1 beat, reaching a peak near $277 by early June before pulling back to the $220–$235 range through mid-June to late June, then re-accelerating through July. The performance decomposition data confirms the rally has been almost entirely multiple-driven: NTM EV/EBITDA expanded from ~47× to ~81× over the past 3 months (+73%), while NTM EV/Sales expanded from ~11× to ~20× (+80%). At current levels, DDOG trades at approximately 20× NTM revenue and 81× NTM EBITDA — a premium that requires sustained 25%+ revenue growth and continued AI monetization to justify. The sector ETF used is IGV (iShares Expanded Tech-Software ETF), which is the most appropriate benchmark for a cloud-native SaaS observability company.
Key Takeaway: The most important development since Q1 earnings is the DASH user conference (June 2026), which served as a major AI product showcase and reinforced the company's platform narrative; no negative developments have emerged, and the news flow has been uniformly positive for the bull case.
Key Takeaway: Every peer that reported in the last 60 days and commented on the quarter overlapping DDOG Q2 2026 (April–June / May–July 2026) described accelerating AI-driven cloud consumption, strong enterprise demand, and growing agentic workloads — a uniformly positive read-through for Datadog's Q2 results. The one nuance is GitLab's caution on the price-sensitive SMB cohort, which is less relevant given DDOG's enterprise concentration.
Note on methodology: Only forward-looking commentary from peer earnings calls that specifically addresses the peer's then-current or upcoming quarter overlapping DDOG Q2 2026 (April–June 2026) is included below. Retrospective commentary about a peer's already-reported quarter is excluded.
Reporting period: FY Q1 (Feb–Apr 2026). Forward commentary covers Q2 FY2027 (May–Jul 2026), which overlaps DDOG Q2 2026.
Reporting period: FY Q1 (Feb–Apr 2026). Forward commentary covers Q2 FY2027 (May–Jul 2026), which overlaps DDOG Q2 2026.
Reporting period: FY Q1 (Feb–Apr 2026). Forward commentary covers Q2 FY2027 (May–Jul 2026), which overlaps DDOG Q2 2026.
Reporting period: FY Q4 (Feb–Apr 2026). Forward commentary covers Q1 FY2027 (May–Jul 2026), which overlaps DDOG Q2 2026.
Reporting period: FY Q1 (Feb–Apr 2026). Forward commentary covers Q2 FY2027 (May–Jul 2026), which overlaps DDOG Q2 2026.
Peer | Event Date | Forward Quarter Covered | Key Signal for DDOG Q2 | Read-Through Direction |
CrowdStrike (CRWD) | June 3, 2026 | Q2 FY27 (May–Jul 2026) | AI demand inflection; record Q2 pipeline; agentic workload explosion | Strongly Positive |
Snowflake (SNOW) | May 27, 2026 | Q2 FY27 (May–Jul 2026) | Guidance raised; AI accelerating core consumption; 114% YoY workload growth | Strongly Positive |
MongoDB (MDB) | May 28, 2026 | Q2 FY27 (May–Jul 2026) | Atlas +26% growth; AI/agentic momentum; observability cited as key requirement | Positive |
Elastic (ESTC) | May 28, 2026 | Q1 FY27 (May–Jul 2026) | AI driving growth; CRPO +20%; minor competitive note on Prometheus metrics | Positive (with minor caveat) |
GitLab (GTLB) | June 2, 2026 | Q2 FY27 (May–Jul 2026) | Agentic tailwinds; code push +49% YoY; SMB caution (limited DDOG relevance) | Positive (enterprise); Neutral (SMB) |
Key Takeaway: All insider transactions since the Q1 2026 earnings print are sales, but virtually all are under pre-established 10b5-1 plans — routine, obligation-driven, and not discretionary signals. The one exception is a small cluster of non-10b5-1 sales on June 2 (the day of the DASH conference) by multiple executives, which appears to be a scheduled RSU vesting event rather than a discretionary sell signal. No open-market buys have been filed.
Name | Title | Transaction Type | Shares | Transaction Date | Note |
Pomel, Olivier | CEO & Director | 10b5-1 Planned Sale | 127,141 | Jul 13, 2026 | Pre-planned; routine 10b5-1 plan (est. Dec 15, 2025) |
Pomel, Olivier | CEO & Director | 10b5-1 Planned Sale | 47,054 | Jul 23, 2026 | Pre-planned; routine 10b5-1 plan |
Pomel, Olivier | CEO & Director | 10b5-1 Planned Sale | 84,698 | Jun 16, 2026 | Pre-planned; routine 10b5-1 plan |
Pomel, Olivier | CEO & Director | Open Market Sale (non-10b5-1) | 26,012 | Jun 2, 2026 | Non-10b5-1; likely RSU vesting event (same-day sales by multiple executives) |
Pomel, Olivier | CEO & Director | 10b5-1 Planned Sale | 84,698 | May 26, 2026 | Pre-planned; routine 10b5-1 plan |
Pomel, Olivier | CEO & Director | 10b5-1 Planned Sale | 127,141 | May 11, 2026 | Pre-planned; routine 10b5-1 plan |
Le-Quoc, Alexis | CTO & Director | 10b5-1 Planned Sale | 43,224 | Jul 20, 2026 | Pre-planned; routine 10b5-1 plan (est. Jun 13, 2025) |
Le-Quoc, Alexis | CTO & Director | 10b5-1 Planned Sale | 53,912 | Jul 8, 2026 | Pre-planned; routine 10b5-1 plan |
Le-Quoc, Alexis | CTO & Director | 10b5-1 Planned Sale | 43,224 | Jun 22, 2026 | Pre-planned; routine 10b5-1 plan |
Obstler, David M. | CFO | 10b5-1 Planned Sale | 75,000 | Jun 8, 2026 | Pre-planned; routine 10b5-1 plan |
Obstler, David M. | CFO | Open Market Sale (non-10b5-1) | 16,323 | Jun 2, 2026 | Non-10b5-1; likely RSU vesting event (same-day cluster) |
Agarwal, Amit | Director | 10b5-1 Planned Sale (via Trust) | 20,000 (per tranche) | Multiple dates (Jun–Jul 2026) | Recurring 20,000-share tranches; highly systematic 10b5-1 plan |
Callahan, Michael James | Director | 10b5-1 Planned Sale (via Trust) | 12,500–112,500 | Jun–Jul 2026 | Pre-planned; routine 10b5-1 plan |
Blitzer, Adam | COO | 10b5-1 Planned Sale | 13,642 | Jun 2, 2026 | Pre-planned; routine 10b5-1 plan |
Walters, Sean Michael | Chief Revenue Officer | 10b5-1 Planned Sale | 11,876 | Jun 11, 2026 | Pre-planned; routine 10b5-1 plan |
Source: SEC Form 4 Filings Database (Insider Transaction Data). The overwhelming majority of insider sales since the Q1 2026 earnings print are under pre-established 10b5-1 trading plans, making them obligation-driven rather than discretionary. The June 2 cluster of non-10b5-1 sales across multiple executives (Pomel, Obstler, Blitzer, Walters, Li, Galloreese, Acocella) is consistent with a scheduled RSU vesting event rather than a coordinated discretionary sell decision. Director Amit Agarwal's recurring 20,000-share tranches are highly systematic. Overall assessment: no unusual or concerning insider activity; the pattern is consistent with normal executive compensation plan execution.